Pages that link to "Q39676203"

The following pages link to Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. (Q39676203):

Displaying 50 items.

• Targeting EZH2 in cancer (Q26769027) ‎ (← links)
• A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor (Q27003534) ‎ (← links)
• Elucidating distinct roles for NF1 in melanomagenesis (Q27851952) ‎ (← links)
• Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK (Q28833740) ‎ (← links)
• Modulation of oxidative stress as an anticancer strategy (Q29615707) ‎ (← links)
• Integrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers (Q30397531) ‎ (← links)
• Targeting pathways downstream of KRAS in lung adenocarcinoma (Q30597330) ‎ (← links)
• Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. (Q33737662) ‎ (← links)
• Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma (Q33757003) ‎ (← links)
• Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors (Q33763742) ‎ (← links)
• Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response (Q33778215) ‎ (← links)
• Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease (Q33828303) ‎ (← links)
• XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway (Q33926690) ‎ (← links)
• Cellular senescence and protein degradation: breaking down cancer (Q33953067) ‎ (← links)
• MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. (Q34022861) ‎ (← links)
• Small RNA combination therapy for lung cancer (Q34120092) ‎ (← links)
• The NF1 gene revisited - from bench to bedside (Q34227509) ‎ (← links)
• Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy (Q34245117) ‎ (← links)
• HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models (Q34793260) ‎ (← links)
• KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer (Q34793532) ‎ (← links)
• Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells (Q34926558) ‎ (← links)
• Antitumor effect of fructose 1,6-bisphosphate and its mechanism in hepatocellular carcinoma cells (Q35003020) ‎ (← links)
• Not just gRASping at flaws: finding vulnerabilities to develop novel therapies for treating KRAS mutant cancers (Q35051540) ‎ (← links)
• The study of inducing apoptosis effect of fructose 1,6-bisphosphate on the papillary thyroid carcinoma cell and its related mechanism (Q35084949) ‎ (← links)
• The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells (Q35121301) ‎ (← links)
• Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers (Q35657827) ‎ (← links)
• Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes (Q35823218) ‎ (← links)
• Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis (Q35887283) ‎ (← links)
• Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy (Q35912293) ‎ (← links)
• Emerging insights into the molecular and cellular basis of glioblastoma (Q35914897) ‎ (← links)
• Combination of Rad001 (everolimus) and propachlor synergistically induces apoptosis through enhanced autophagy in prostate cancer cells (Q36028196) ‎ (← links)
• Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancer (Q36173303) ‎ (← links)
• Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG. (Q36312850) ‎ (← links)
• KRAS mutant lung cancer: progress thus far on an elusive therapeutic target (Q36369197) ‎ (← links)
• Therapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM) (Q36462100) ‎ (← links)
• Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy (Q36465517) ‎ (← links)
• Impact of deleterious passenger mutations on cancer progression (Q36637272) ‎ (← links)
• RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas (Q36763119) ‎ (← links)
• Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers (Q36799584) ‎ (← links)
• Personalizing therapy in advanced non-small cell lung cancer (Q36811453) ‎ (← links)
• Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin (Q36896039) ‎ (← links)
• Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes (Q36926098) ‎ (← links)
• D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis (Q37189245) ‎ (← links)
• Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. (Q37201739) ‎ (← links)
• The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies (Q37285838) ‎ (← links)
• A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS. (Q37377959) ‎ (← links)
• A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer (Q37417712) ‎ (← links)
• Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer. (Q37455251) ‎ (← links)
• Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target (Q37517660) ‎ (← links)
• The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells (Q37564440) ‎ (← links)